Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GLP-1 RA medications used in this patient population significantly lowered the risk of atrial fibrillation-related events for patients with diabetes, atrial fibrillation (AF), and obesity, with a particular benefit observed for those with severe obesity (TRANSFORM-AF study, Heart Rhythm 2025
One is Virta Health, which advertises its nutrition-focused weight management program as a proven approach for deprescribing GLP-1s when clinically appropriate. A Virta-funded study assessed 154 people with Type 2 diabetes who stopped using GLP-1 medications but continued following Virtas program, concluding that their weight did not significantly increase after a year
EMSs Ozivy was registered earlier and may already be available
Why not, you know, for people using GLP-1?"
most side effects diminish over time as your body adjusts
Contact your healthcare provider promptly if you develop jaundice (yellowing of skin or eyes), dark-colored urine, pale stools, persistent right upper quadrant abdominal pain, or unexplained severe fatigue
